TrialClinical lung cancer2016

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Kai-Lin Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.